Discover iDose TR at ReFocus Eye Health North Wales
What is iDose TR?
iDose TR is a tiny, medical-grade implant that delivers a steady supply of glaucoma medication inside your eye, reducing or eliminating the need for daily drops. Our eye doctors at ReFocus Eye Health North Wales use this innovative therapy to support long-term pressure control and simplify glaucoma management for our patients.
Unlike traditional daily eye drops, iDose TR works around the clock from within your eye, helping keep pressure stable and lowering the risk of missed doses or medication errors. This can make glaucoma treatment much easier, especially for patients with busy lives.
The implant is built from durable titanium and uses a special membrane to gradually release travoprost, a proven glaucoma medication. It sits in the eye’s natural drainage system (trabecular meshwork) and typically lowers eye pressure by about 30% based on clinical studies.
iDose TR was created by Glaukos Corporation and received FDA approval in 2023 for adult patients. It aims to solve common frustrations with glaucoma drop routines by delivering reliable, long-term therapy.
Extensive clinical research shows iDose TR is both safe and effective. Most patients enjoy low complication rates, good device retention, and significant improvements in pressure control.
What makes iDose TR unique is its focus on the trabecular meshwork, targeting the main area for glaucoma treatment and medication delivery, rather than other structures inside the eye.
How Does iDose TR Work?
iDose TR is placed into the eye with a quick outpatient procedure at our North Wales office, constantly releasing medication to help keep eye pressure stable and ease daily routines.
Insertion takes around 30 minutes and uses numbing drops to keep you comfortable. Our eye doctors use special tools to gently position the device for best results, allowing you to return home soon after.
Once implanted, iDose TR slowly releases travoprost, a medication that helps your eye drain fluid more efficiently, leading to steadier pressure and fewer spikes or drops.
Most patients get 2 to 3 years of continuous treatment from a single iDose TR before considering replacement or removal during a similar outpatient visit.
Regular check-ups at ReFocus Eye Health North Wales help us track your eye pressure and implant performance, using imaging tests and in-person evaluations as needed.
Benefits of iDose TR
iDose TR offers a number of benefits that can make glaucoma management simpler and more effective, especially for patients in North Wales, Montgomery County, and the Greater Philadelphia Region.
With no daily drops to remember, iDose TR can cut down on pharmacy visits and reduce the worry of missed or skipped doses.
The steady release of medication results in a more stable eye pressure, which is important for slowing glaucoma progression and protecting vision.
Consistent treatment can lower the risk of vision loss, especially for patients who have trouble sticking with traditional medication routines.
Delivering medication directly inside the eye often reduces the side effects that some patients experience with topical drops, such as irritation or allergic reactions.
Many patients need fewer additional medications, which simplifies treatment and can make glaucoma care less complicated.
Patients can enjoy more freedom, whether traveling, working, or exercising, without worrying about eye drop schedules.
Who Can Benefit from iDose TR?
iDose TR is a strong choice for many adults living with open-angle glaucoma or ocular hypertension. It may especially help those in North Wales and nearby communities who need an easier solution for long-term control.
Patients who struggle with daily drops, have busy schedules, or experience side effects from traditional medications often find iDose TR to be helpful.
This implant is mainly used for open-angle glaucoma and ocular hypertension, both of which can damage the optic nerve if not controlled.
iDose TR may not be recommended for patients with certain eye infections, allergies to travoprost, narrow-angle glaucoma, or those who are pregnant or nursing.
Our eye doctors will carefully review your health history, eye conditions, and overall needs to determine if iDose TR could be the best option for you.
The iDose TR Procedure
At ReFocus Eye Health North Wales, iDose TR is placed during a convenient outpatient visit, allowing most patients to head home the same day.
We provide clear instructions before the procedure, which may include adjusting certain medications and arranging transportation for your comfort.
Your eye will be safely numbed and a small opening will be made to place the implant in the trabecular meshwork. Most patients experience minimal discomfort.
It's important to rest, use prescribed eye drops to prevent infection, and avoid heavy lifting or rubbing your eye for a few days. We schedule follow-up visits to help monitor healing and implant success.
Most patients experience mild redness, irritation, or blurry vision that resolves quickly. Everyday activities are usually resumed within several days.
Potential Risks and Side Effects
All medical treatments carry some risks. At ReFocus Eye Health North Wales, we prioritize safety, monitoring for any concerns and providing guidance on side effect management.
Patients may notice temporary redness, irritation, or blurry vision after the procedure, but these typically resolve in a few days.
Rare complications can include infection, inflammation, or implant movement. These are usually treatable when recognized early.
If you experience any severe pain, changes in vision, or signs of infection, contact our office promptly. Most patients tolerate iDose TR very well.
Patients quickly adjust to the implant, and our team offers routine check-ups to track vision and implant health over time.
Frequently Asked Questions About iDose TR
Here are answers to some of the most common questions patients from North Wales, Lansdale, Norristown, and throughout the Greater Philadelphia Region ask about iDose TR.
No, the procedure uses strong numbing drops, and most patients feel little to no discomfort. Any mild symptoms after are typically brief.
The implant usually works for 2 to 3 years, after which it can be replaced if needed.
Many patients reduce or stop using glaucoma drops following iDose TR, but your doctor will advise based on your unique situation.
Insurance coverage varies, but many plans provide benefits for qualifying patients. We can help with questions about coverage and authorization.
No, iDose TR is very small and placed where you cannot see or feel it in daily life.
Most people recover quickly, resuming normal routines within a few days.
After you heal, you can continue with your daily life without restrictions from the implant itself.
Yes, iDose TR is designed for safe removal or replacement if necessary.
iDose TR is less invasive than traditional glaucoma surgeries and typically allows for a quicker recovery.
Patients can have implants placed in both eyes depending on their individual needs and doctor’s recommendation.
Your eye doctor can remove the implant and place a new one if you require continued treatment.
Yes, studies have shown iDose TR is safe for adults of all ages, including seniors.
For many patients, iDose TR provides excellent control, but some may still need additional treatments.
Regular follow-ups are important, usually every few months until your eye pressure stabilizes.
Avoid rubbing your eyes and swimming in untreated water for the first few weeks after surgery. Other typical activities can resume quickly.
There is no evidence that iDose TR causes cataracts, and it can be safely managed if cataract surgery is needed later.
Interactions are unlikely, but always inform your eye doctor about your full health and medication history.
Contact ReFocus Eye Health North Wales promptly if you notice vision changes, significant pain, or new symptoms after the procedure.
Take the Next Step Toward Clearer Vision
At ReFocus Eye Health North Wales, we’re committed to providing expert care and advanced solutions for glaucoma. If you or a loved one are considering iDose TR, our team is here to answer your questions and guide you through every stage of care in North Wales and the Greater Philadelphia Region.
Dr. Barouh continues as a wonderful doctor, helping me with glaucoma.
Cecily Selling
Linda and Dr. Barouh made my glaucoma visit smooth. Dr. Barouh explained next steps for my treatment and visits.
Karen Vaughan-Houseal
Dr. Lindsey Barouh and front desk did a great job. Everything was on time and thorough.
Betty Sanna
Dr. Clark was very caring and thorough. Helped diagnose an issue that was going unsolved and got me on the right treatment plan.
Susan Westington
Dr. Barouh is thorough, professional, and takes her time. She is also very nice. I am always happy to see her!
Eileen Scheck-Estock
Contact Us
Tuesday: 8am-4pm
Wednesday: 8am-4pm
Thursday: 8am-4pm
Friday: 8am-4pm
Saturday: Closed
Sunday: Closed